Search results for: 'Global Precision Oncology Market Trends and Growth Opportunities'

01 Sep 2020  |  North America  |  Market Research

Oncology Information Systems to Drive Robustness in Care Delivery, Forecast to 2024

Future Growth Potential Lies in Precision Medicine and Cloud Adoption in Oncology Care

Infographics

×

As cancer care becomes increasingly highly complex, the information, image data, and steps that comprise a single patients healthcare journey has grown tremendously. Oncology information systems (OIS) software are used by cancer clinics and departments, medical oncologists, radiation specialists, and department employees to manage and plan the trea...

Precision medicine is transitioning toward wider acceptance, due to mounting payer pressures and regulatory changes that are shifting pharma businesses from prescriptive to more predictive and personalized models. Emergence of value-based reimbursement models and healthcare consumerism trends are helping move the treatment model from ‘one-size-fits...

08 Sep 2016  |  Global  |  Market Research

Growth Opportunities for Healthcare Big Data—An Analysis of Global Case Studies

Big Data Initiatives Targeted at Health Prediction and Precision

Infographics

×

The healthcare industry has been a laggard in Big Data adoption as compared to other verticals and continues to battle challenges around interoperability, budget constraints, and insufficient strategic planning and change management. However, the intent to leverage the power of Big Data is evident across all industry stakeholders, including governm...

The pharmaceutical and biotechnology industries are entering a transformative era in 2025, shaped by a convergence of scientific innovation, regulatory evolution, and market pressures. One of the key imperatives is the continued advancement of therapeutics and drug approvals, as breakthrough treatments, particularly in personalized medicine, promis...

The concept of companion diagnostics (CDx) was developed when researchers realized that even potent drugs only had an efficacy between 25% and 60%, the lowest being in oncology. Therefore, a clinical pharmacogenetic assay became important to distinguish patients more likely to respond to a drug or at a lesser risk of associated adverse pathophysiol...

With digital transformation and organizations transitioning to the cloud, network access control (NAC) solutions have moved from strengthening an organization’s internal infrastructure security to supporting unique policies on how and when endpoints connect to networks. NAC products and services offer visibility into and control over endpoints atte...

The Satellite-based IoT sector is poised for unprecedented growth, driven by technological advancements and increasing demand for global connectivity. This study explores the pivotal growth opportunities within the sector, highlighting how innovations in satellite technology, strategic industry convergence, and emerging market dynamics are shaping ...

The residential solar PV segment is witnessing a period of fast growth, driven by a combination of an increasingly favorable regulatory climate, higher electricity prices, and concerns over climate change. The restraints that have held the market back, primarily delays in approvals, have grown weaker, as governments gradually tackle these issues. T...